Skip to content

Article: Cockayne Syndrome Proteins Maintain Mitochondrial Health Through NAD+ Signaling: Preclinical Findings

Cockayne Syndrome Proteins Maintain Mitochondrial Health Through NAD+ Signaling: Preclinical Findings


Synopsis

Cockayne syndrome (CS) is a rare premature aging disorder involving DNA repair defects and mitochondrial dysfunction. Across human, mouse, and nematode models, mitochondrial dysfunction was a consistent feature. NAD+ supplementation improved lifespan and healthspan in nematode models, and NAD+ precursors, such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) corrected mitochondrial issues in CS patient cells. The findings link DNA damage, mitochondrial dysfunction, and poor cellular cleanup processes (mitophagy/autophagy) as drivers of accelerated aging in CS—issues that can be partly reversed by restoring NAD+.

Journal

Aging Cell

Read more

Kidney Disease

Nicotinamide Riboside Protects Against Acute Kidney Injury but Not Chronic Kidney Disease: Preclinical Findings

Synopsis Nicotinamide adenine dinucleotide (NAD+) is essential for kidney function, but its production is impaired in acute kidney injury (AKI) and chronic kidney disease (CKD). In human kidney bi...

Read more
Amyotrophic Lateral Sclerosis (ALS)

Nicotinamide Riboside and Pterostilbene Protect Motor Neurons in ALS: Preclinical Findings

Synopsis Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that causes the gradual loss of motor neurons, largely due to oxidative stress and inflammation. In both human trials an...

Read more